Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Frasca L
Front Immunol. 2018 Sep 12;9:1936. doi: 10.3389/fimmu.2018.01936
Bacterial transport suppressed by fluid shear
Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin.
Capasso Palmiero U
J Control Release. 2018 Mar 7;276:140-149. doi: 10.1016/j.jconrel.2018.03.005
Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response.
Cesca M
Mol Cancer Ther. 2015 Oct 22;15(1):125-35. doi: 10.1158/1535-7163.MCT-15-0063
Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.
Ansaloni L
Br J Cancer. 2014 Dec 2;112(2):306-12. doi: 10.1038/bjc.2014.602
Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.
Maiolo D
ACS Nano. 2017 Aug 17;11(9):9413-9423. doi: 10.1021/acsnano.7b04979
Application of 3D Mass Spectrometry Imaging to TKIs.
Morosi L
Clin Pharmacol Ther. 102(5):748-751. doi: 10.1002/cpt.786
Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imaging.
Morosi L
Int J Biol Sci. 2020 Feb 21;16(8):1363-1375. doi: 10.7150/ijbs.41395
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models.
Morosi L
J Exp Clin Cancer Res. 2021 Sep 10;40(1):286. doi: 10.1186/s13046-021-02070-x
Regulatory T cells mediate maternal tolerance to the fetus.
Aluvihare VR, Kallikourdis M, Betz AG
Nat Immunol. 2004 Feb 1;5(3):266-71.